Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. - Wikidata - wikimedia - TriplyDB

Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.

Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.

http://www.wikidata.org/entity/Q37690429

about

Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery Large oncosomes mediate intercellular transfer of functional microRNA.Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors.Caveolin-1: An Oxidative Stress-Related Target for Cancer Prevention.Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer.Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.Estrogen receptor β exon 3-deleted mouse: The importance of non-ERE pathways in ERβ signaling Expression of ERG protein in prostate cancer: variability and biological correlates.Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas.Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China.High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting Loss of caveolin-1 alters extracellular matrix protein expression and ductal architecture in murine mammary glands Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers.Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.Stromal Modulators of TGF-β in Cancer.The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma.Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review).Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance Quantitative proteomic Analysis Reveals up-regulation of caveolin-1 in FOXP3-overexpressed human gastric cancer cells.The Role of Nitric Oxide from Neurological Disease to Cancer.Genetic variation at the microRNA binding site of CAV1 gene is associated with lung cancer susceptibility.Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells.Rho/ROCK Pathway Regulates Migration and Invasion of Esophageal Squamous Cell Carcinoma by Regulating Caveolin-1.The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.Expression of caveolin-1 in breast cancer stroma as a potential prognostic biomarker of survival and progression: a meta-analysis.Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases.Caveolin-1-Knockout Mouse as a Model of Inflammatory Diseases Comparing the expression profiles of steroid hormone receptors and stromal cell markers in prostate cancer at different Gleason scores

P2860

Q26851813-37B325E7-70FD-4EF3-B527-E747E8E2446B Q30570006-2DF70284-1D3A-4ACE-B89D-74854ECC40B7 Q30652492-1408CD2F-2CD3-4162-83C5-DB5E1341B038 Q33701745-8C4C7CD2-7598-4261-9469-53B5E189892F Q33783855-92C81F94-84B2-4A5B-A9A7-0DE6244D70ED Q35012038-56BE192C-E624-491C-95BC-6760455B8FDF Q35088099-3E625EE3-C47F-4DC4-B9DC-AEC266EFCE90 Q35549236-4F8F06EB-5327-4A16-A979-F6AA29369800 Q35608000-E21AFEA6-5DEA-440B-95DE-64A77C9F3372 Q35727558-C7F947C4-EF6B-4E22-A331-002D51B04430 Q35840904-1374A899-F482-4AD3-822F-1CF1C14F524B Q36140962-5E195DFA-3B9B-44A2-8A46-6E4E88D073E6 Q36168963-009F2BB6-67C6-4D2C-B419-338FBF498F87 Q36276995-C7121575-4E18-4164-8F5A-FD61A7D27751 Q36423203-F993782F-600A-47C2-8AB3-549DE2312069 Q37361227-3F3A8F40-8608-47A0-9C09-5773098EA9F9 Q37396904-B3396464-67E3-452E-B2D2-A7A1F559FEB6 Q37628179-283D0154-C0A7-43BA-AFC7-7521BBB5A6E9 Q37652986-78E9E37D-541B-4B11-AC7D-82BC9E43AB0F Q38247284-C4EA6407-E0E5-4CB4-B938-DD762933708B Q41535142-11C01F0C-5A5D-4CB5-B87C-487107401D68 Q42121834-FED988C4-BE8F-4D67-8AC4-165C905DDD6E Q45901711-B93CC0EB-2922-403A-BC62-C550647000C0 Q46141259-74FAA6FA-C707-46BA-81D5-7212F038A447 Q47146869-A7158ECF-E28F-4131-B949-37661FBB40F4 Q47285805-9C4D1952-5FDB-46E5-8F0F-1E77D48C93D3 Q47710385-4CE88806-25DA-4152-86F4-555AB58CB4ED Q49485211-1A9B35F2-7EDE-4682-BA83-CDA09EEDD88D Q51416808-0AF9729E-D856-4D1F-9553-D32FD3DE6C75 Q53388239-F8BAC76D-1ADA-4966-849C-A17C1A02A9E3 Q55401220-638F8955-A2A1-43B7-ACB1-5922F44F2D9D Q58693363-65F469F4-6D6C-4BDA-977A-D3BBDCCF86F8 Q58698662-293CFC08-9C8F-48B5-86E0-56E6DF8B01C1

P2860

Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.

http://www.wikidata.org/entity/Q37690429

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Loss of caveolin-1 in prostate ...... elevant to tumour progression.

@en

Loss of caveolin-1 in prostate ...... elevant to tumour progression.

@nl

type

label

Loss of caveolin-1 in prostate ...... elevant to tumour progression.

@en

Loss of caveolin-1 in prostate ...... elevant to tumour progression.

@nl

prefLabel

Loss of caveolin-1 in prostate ...... elevant to tumour progression.

@en

Loss of caveolin-1 in prostate ...... elevant to tumour progression.

@nl

P1433

Q37690429-1F5A0744-3C9B-44AF-B58B-DA7A555A276F

P1476

Q37690429-B73E3520-1886-423B-AB8F-4B4E8D0E61B2

P2093

Q37690429-1AD8D6D8-A077-4E1C-96AD-1F536DB9C771

Q37690429-1F9F3C9E-81E3-4CE2-9422-0AAC446CB790

Q37690429-5D3C10E4-48B2-405E-B200-4D7046969440

Q37690429-5FE33EB4-959F-4CD9-AF6F-9A08D7B3ED96

Q37690429-83CAA85B-1CAC-42AA-9410-F43D8C922D52

Q37690429-89C82075-1C21-42CF-B73D-08FB05AB5529

Q37690429-8D166983-0DB0-4218-ADDD-D6B5F18B669D

Q37690429-94C4545D-1083-49AD-9F40-FCCA66A98907

Q37690429-AA9050BC-02CE-43DB-9DD4-14001228DF55

Q37690429-AE53236A-1A19-48ED-9DB9-F84A7F9487C3

P2860

Q37690429-0AFF4301-1537-45DF-A168-F86E21AEF452

Q37690429-0ED1CDF1-4AB9-4148-9580-ED14A9D7870D

Q37690429-116EFD57-C6A9-4B9F-B0D4-624AAA6D2F4F

Q37690429-11BB8954-2703-4D60-993A-7660C21046A9

Q37690429-12D8F48E-364A-4A30-9D54-046FCD544F70

Q37690429-12EA6D4F-97E1-4800-8FFE-231BD9AEBB27

Q37690429-17376BA7-5EAB-4D96-9932-30D55E251766

Q37690429-175AF215-FB04-4DDB-AA18-77D67CF50638

Q37690429-209184CA-370A-44CA-BE0B-C63CEA75371F

Q37690429-28E47779-35C2-4DF3-987B-1D44B609B551

P304

Q37690429-B4C1B97F-9612-4693-B8AC-44D87E78E1C8

P31

Q37690429-3EA51FDA-D366-4A5C-BD0E-301A99DA344E

P356

Q37690429-66F6BC85-AFDA-47BE-9A24-7634C95F4E2D

P433

Q37690429-59EADC99-6D96-4DA9-AD7D-B8174FCA7D4E

P478

Q37690429-29EA0A32-F74E-46A0-8610-C3196B53D7C7

P50

Q37690429-E2C9475F-CF79-432B-97DE-64989DD1F432

P577

Q37690429-C973F23D-4DC3-4B9A-8D3A-6C92891EF8D6

P5875

Q37690429-B9E5E77A-40FC-4496-9F4D-5A71AC2D4AE6

P698

Q37690429-7CD95126-F412-47FB-B4DB-20B6EEE89E67

P932

Q37690429-78B90070-5122-4382-812A-66DDC23FE17A

P356

P1433

The Journal of Pathology

P1476

Loss of caveolin-1 in prostate ...... elevant to tumour progression.

@en

P2093

Anna Frolov

http://www.w3.org/2001/XMLSchema#string

Dolores Di Vizio

http://www.w3.org/2001/XMLSchema#string

Fabiana Rosati

http://www.w3.org/2001/XMLSchema#string

Gianluca Bartolucci

http://www.w3.org/2001/XMLSchema#string

Giovanna Danza

http://www.w3.org/2001/XMLSchema#string

Gustavo Ayala

http://www.w3.org/2001/XMLSchema#string

Matteo Morello

http://www.w3.org/2001/XMLSchema#string

Michael R Freeman

http://www.w3.org/2001/XMLSchema#string

Rile Li

http://www.w3.org/2001/XMLSchema#string

Rosalyn M Adam

http://www.w3.org/2001/XMLSchema#string

P2860

CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B

NCBI GEO: archive for functional genomics data sets--10 years on

An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers

Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture

Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland

Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.

Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease

Quantification of epithelial cells in coculture with fibroblasts by fluorescence image analysis.

Simultaneous quantitation of testosterone and estradiol in human cell line (H295R) by liquid chromatography/positive atmospheric pressure photoionization tandem mass spectrometry.

P304

77-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.4217

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

231

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. Lisanti

P577

2013-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237013689

http://www.w3.org/2001/XMLSchema#string

P698

23729330

http://www.w3.org/2001/XMLSchema#string

P932

3978784

http://www.w3.org/2001/XMLSchema#string